AstraZeneca PLC (AZN) Announced Q1 2026 Earnings on April 29, 2026, Reporting "Total revenue grew 8% in the quarter".
AstraZeneca PLC announced Q1 2026 earnings, with total revenue increasing by 8% to $6.8 billion, driven by strong demand for innovative medicines. Core operating profit rose 12%, and core EPS grew 5% to $2.58.